SCHEMBL9708645

SCHEMBL9708645

Cc1nc2c(c(=O)[nH]c(=O)n2CC2CC2)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
HTT P42858 3/20 0.42
HPGD P15428 2/20 0.42
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 8/20 0.41
MEN1 O00255 7/20 0.41
NPSR1 Q6W5P4 4/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TSHR P16473 2/20 0.40
AGTR1 P30556 2/20 0.39
AGTR2 P50052 2/20 0.39
POLB P06746 2/20 0.39
PKM P14618 2/20 0.39
MCL1 Q07820 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ADORA3 P0DMS8 1/20 0.38
RAB9A P51151 1/20 0.38
PDE5A O76074 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708230 0.90 KMT2A (0.45) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708857 0.90 ALDH1A1 (0.39) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9707767 0.89 MEN1 (0.50) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708379 0.89 MEN1 (0.46) ALDH1A1KDM4EHTTKMT2AMEN1
SCHEMBL9707658 0.88 KMT2A (0.41) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9707770 0.87 AGTR1 (0.50) KMT2AMEN1AGTR1AGTR2
SCHEMBL9708067 0.87 PDE5A (0.51) AGTR1AGTR2ADORA3PDE5APDE4A
SCHEMBL9707484 0.87 KDM4E (0.49) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9708799 0.87 KMT2A (0.51) ALDH1A1KDM4EHTTHPGDMAPT
SCHEMBL9707461 0.87 AGTR1 (0.48) KMT2AMEN1AGTR1AGTR2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed